000 | 01775 a2200541 4500 | ||
---|---|---|---|
005 | 20250518095224.0 | ||
264 | 0 | _c20201021 | |
008 | 202010s 0 0 eng d | ||
022 | _a1526-7598 | ||
024 | 7 |
_a10.1213/ANE.0000000000004873 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSmereka, Jacek | |
245 | 0 | 0 |
_aRole of Mask/Respirator Protection Against SARS-CoV-2. _h[electronic resource] |
260 |
_bAnesthesia and analgesia _c07 2020 |
||
300 |
_ae33-e34 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAerosols |
650 | 0 | 4 |
_aBetacoronavirus _xpathogenicity |
650 | 0 | 4 | _aCOVID-19 |
650 | 0 | 4 |
_aCoronavirus Infections _xdiagnosis |
650 | 0 | 4 | _aEquipment Design |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHead Protective Devices |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfection Control _xinstrumentation |
650 | 0 | 4 |
_aInfectious Disease Transmission, Patient-to-Professional _xprevention & control |
650 | 0 | 4 |
_aInhalation Exposure _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMasks |
650 | 0 | 4 |
_aOccupational Exposure _xadverse effects |
650 | 0 | 4 | _aOccupational Health |
650 | 0 | 4 | _aPandemics |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 | _aPersonal Protective Equipment |
650 | 0 | 4 |
_aPneumonia, Viral _xdiagnosis |
650 | 0 | 4 | _aProtective Factors |
650 | 0 | 4 | _aRespiratory Protective Devices |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSARS-CoV-2 |
650 | 0 | 4 | _aVirulence |
700 | 1 | _aRuetzler, Kurt | |
700 | 1 | _aSzarpak, Lukasz | |
700 | 1 | _aFilipiak, Krzysztof Jerzy | |
700 | 1 | _aJaguszewski, Milosz | |
773 | 0 |
_tAnesthesia and analgesia _gvol. 131 _gno. 1 _gp. e33-e34 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1213/ANE.0000000000004873 _zAvailable from publisher's website |
999 |
_c30854208 _d30854208 |